Neuronetics_logo-RGB purple.png
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 21, 2023 08:56 ET | Neuronetics
MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 14, 2023 09:02 ET | Neuronetics
MALVERN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
July 19, 2023 08:56 ET | Neuronetics
MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
July 17, 2023 08:46 ET | Neuronetics
MALVERN, Pa., July 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
July 11, 2023 08:56 ET | Neuronetics
MALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
June 12, 2023 08:59 ET | Neuronetics
MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
May 26, 2023 08:59 ET | Neuronetics
MALVERN, Pa., May 26, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Depression Barometer Infographic
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
May 23, 2023 08:46 ET | Neuronetics
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
May 15, 2023 08:56 ET | Neuronetics
MALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
May 08, 2023 08:47 ET | Neuronetics
MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...